Antithrombotic therapy in valvular heart disease

Steven Droogmans; Simon Vanhentenrijk; Bernard Cosyns

doi:10.1007/978-3-030-23104-0_16

Antithrombotic therapy in valvular heart disease

Steven Droogmans, Simon Vanhentenrijk, Bernard Cosyns

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Research › peer-review

Abstract

Patients with valvular heart disease (VHD) are at increased risk for thrombo-emboligenic events and often require antithrombotic therapy. This needs to be clearly weighted against the bleeding risk as this is often also increased. This chapter will provide an overview of current evidence available in patients with VHD. We will discuss general indications of antithrombotic therapy, its duration, dose, bridging during procedures and treatment options during pregnancy.

Original language	English
Title of host publication	Heart Valve Disease
Subtitle of host publication	State of the Art
Publisher	Springer International Publishing AG
Pages	245-256
Number of pages	12
ISBN (Electronic)	9783030231040
ISBN (Print)	9783030231033
DOIs	https://doi.org/10.1007/978-3-030-23104-0_16
Publication status	Published - 1 Jan 2019

Keywords

Antithrombotic therapy
Bridging
Endocarditis
Indications
Native VHD
Pregnancy
Prosthetic VHD
Rheumatic VHD
Valvular thrombosis

Access to Document

10.1007/978-3-030-23104-0_16

Cite this

@inbook{79015346b5274b70bcf166dfeb51f6e7,

title = "Antithrombotic therapy in valvular heart disease",

abstract = "Patients with valvular heart disease (VHD) are at increased risk for thrombo-emboligenic events and often require antithrombotic therapy. This needs to be clearly weighted against the bleeding risk as this is often also increased. This chapter will provide an overview of current evidence available in patients with VHD. We will discuss general indications of antithrombotic therapy, its duration, dose, bridging during procedures and treatment options during pregnancy.",

keywords = "Antithrombotic therapy, Bridging, Endocarditis, Indications, Native VHD, Pregnancy, Prosthetic VHD, Rheumatic VHD, Valvular thrombosis",

author = "Steven Droogmans and Simon Vanhentenrijk and Bernard Cosyns",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-23104-0_16",

language = "English",

isbn = "9783030231033",

pages = "245--256",

booktitle = "Heart Valve Disease",

publisher = "Springer International Publishing AG",

address = "Switzerland",

}

TY - CHAP

T1 - Antithrombotic therapy in valvular heart disease

AU - Droogmans, Steven

AU - Vanhentenrijk, Simon

AU - Cosyns, Bernard

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Patients with valvular heart disease (VHD) are at increased risk for thrombo-emboligenic events and often require antithrombotic therapy. This needs to be clearly weighted against the bleeding risk as this is often also increased. This chapter will provide an overview of current evidence available in patients with VHD. We will discuss general indications of antithrombotic therapy, its duration, dose, bridging during procedures and treatment options during pregnancy.

AB - Patients with valvular heart disease (VHD) are at increased risk for thrombo-emboligenic events and often require antithrombotic therapy. This needs to be clearly weighted against the bleeding risk as this is often also increased. This chapter will provide an overview of current evidence available in patients with VHD. We will discuss general indications of antithrombotic therapy, its duration, dose, bridging during procedures and treatment options during pregnancy.

KW - Antithrombotic therapy

KW - Bridging

KW - Endocarditis

KW - Indications

KW - Native VHD

KW - Pregnancy

KW - Prosthetic VHD

KW - Rheumatic VHD

KW - Valvular thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85088440221&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-23104-0_16

DO - 10.1007/978-3-030-23104-0_16

M3 - Chapter

AN - SCOPUS:85088440221

SN - 9783030231033

SP - 245

EP - 256

BT - Heart Valve Disease

PB - Springer International Publishing AG

ER -

Antithrombotic therapy in valvular heart disease

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this